It seems Zelda have been well beaten to the punch by an ASX competitor with a skin based medicine.
"Medical marijuana company MGC Pharma has been given the green light to sell its brand new cannabis-based dermatological range of skin care products in the European Union..........."
Its Still only a $44M MC company even after this announcement.
Seems to be quite a crowded space and I'm yet to see what shareholder value ZLD can create for holders in 2017.
https://thewest.com.au/business/pub...medical-cannabis-revenue-stream-ng-b88350801z
It seems Zelda have been well beaten to the punch by an ASX...
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.744M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11589 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 1132 | 1 |
View Market Depth
| Last trade - 07.09am 02/07/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |
Day chart unavailable